BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
US will overhaul childhood vaccine schedule to recommend fewer shots
The US Department of Health and Human Services will recommend fewer vaccines for most American children, health officials…
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
BioXcel Therapeutics sNDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based…
With CDC signoff, CVS says Covid-19 vaccines will be available nationwide without a prescription
The US Centers for Disease Control and Prevention signed off on a recommendation that patients must consult a…
With CDC signoff, CVS says Covid-19 vaccines will be available nationwide without a prescription
The US Centers for Disease Control and Prevention signed off on a recommendation that patients must consult a…
Research shows many women don’t know about simple factor that can slash breast cancer risk: ‘Need for clearer messaging’
Maintaining a balanced and nutritious diet has been linked to a number of improved health benefits for years.…
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia
BioXcel Therapeutics BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2…